Bryant Reeves - Streamline Health Interim Staff
| STRMDelisted Stock | USD 5.33 -0.01 -0.19% |
Executive
Bryant Reeves is Interim Staff of Streamline Health Solutions
| Phone | 888 997 8732 |
| Web | https://www.streamlinehealth.net |
Bryant Reeves Latest Insider Activity
Insider activity for Bryant Reeves can add context to Streamline Health by showing net buying or selling trends across reporting periods. Use filings as supporting evidence, not a standalone signal, because transaction motives can differ.
Bryant Reeves over six months ago Disposition of 1156 shares by Bryant Reeves of Streamline Health at 2.93 subject to Rule 16 b-3 | ||
Bryant Reeves over a year ago Disposition of tradable shares by Bryant Reeves of Streamline Health subject to Rule 16 b-3 |
Streamline Health Management Efficiency
The company has return on total asset (ROA) of -11.1 % meaning that the return on assets was negative, reflecting a $11.1 loss per $100. This sits far below comparable companies. Similarly, it shows a return on stockholder's equity (ROE) of -63.93 %, suggesting that it is drawing down equity without generating offsetting profit.Streamline Health Solutions currently holds $13.12 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is broadly in line with comparable companies. Streamline Health has a current ratio of 0.74, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Note, when we think about Streamline Health's use of debt, we should always consider it together with its cash and equity.
Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Michelle Williams | Elutia Inc | 51 | |
| Charles Pauza | Traws Pharma | 71 | |
| Sonali Fonseca | Elutia Inc | N/A | |
| Matthew Ferguson | Elutia Inc | 58 | |
| Jeffry Hamet | Elutia Inc | N/A | |
| Pete Ligotti | Elutia Inc | N/A | |
| Dwayne Montgomery | Elutia Inc | 58 | |
| Erica Elchin | Elutia Inc | N/A | |
| Robert MD | Traws Pharma | 74 | |
| Nora Brennan | Traws Pharma | 56 | |
| Courtney Guyer | Elutia Inc | N/A | |
| Charles Parker | Traws Pharma | 46 | |
| Mark CPA | Traws Pharma | 56 | |
| C Pauza | Traws Pharma | N/A | |
| Victor MD | Traws Pharma | 57 | |
Management Performance
| Return On Equity | -0.64 | |||
| Return On Asset | -0.11 |
Streamline Health Leadership Team
Elected by the shareholders, the Streamline Health's board of directors comprises two types of representatives: Streamline Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Streamline. The board's role is to monitor Streamline Health's management team and ensure that shareholders' interests are well served. Streamline Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Streamline Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Ben Stilwill, President | ||
| Donald Vick, Director Analytics | ||
| Bryant Reeves, Interim Staff | ||
| Wyche III, Executive Chairman | ||
| Lance Seach, Senior Development | ||
| Jawad Shaikh, Chief Officer | ||
| Benjamin Stilwill, Chief Officer | ||
| Jacob Goldberger, Director Finance | ||
| Wendy Lucio, Chief Officer | ||
| Wendy Lovvorn, Chief Officer | ||
| Amy Sebero, Chief Officer | ||
| Thomas Gibson, CFO, Senior Vice President | ||
| Bryant III, Chief Officer | ||
| MB CCS, VP eValuator |
Streamline Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Streamline Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.64 | |||
| Return On Asset | -0.11 | |||
| Profit Margin | -0.49 % | |||
| Operating Margin | -0.71 % | |||
| Current Valuation | 35.76 M | |||
| Shares Outstanding | 4.36 M | |||
| Shares Owned By Insiders | 17.44 % | |||
| Shares Owned By Institutions | 27.53 % | |||
| Number Of Shares Shorted | 14.43 K | |||
| Price To Earning | 321.67 X |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try Portfolio ProphetStreamline Health has a market cap of 23.23 M, operating margin of -71.44%, ROE of -63.93%. World Market Map adds portfolio-level perspective. The portfolio structure is presented for analytical context. The view is constructed from recorded portfolio positions. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. Streamline Health P/E of 321.67 alongside ROE at -63.93% frames the starting point - the resources below add portfolio-level context that single-security analysis cannot provide alone. Within the Healthcare space, these metrics give the peer comparison tools below a concrete starting point for relative analysis. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Consideration for investing in Streamline Stock
Streamline Health should be evaluated with attention to reporting frequency and market depth.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |